Preproghrelin-derived peptide, obestatin, fails to influence food intake in lean or obese rodents

Obesity

Volumn 15, Issue 11, 2007, Pages 2643-2652

  Gourcerol, Guillaume ^a   Coskun, Tamer ^c   Craft, Libbey S ^c   Mayer, John P ^c   Heiman, Mark L ^c   Wang, Lixin ^a   Million, Mulugeta ^a   St Pierre, David H ^d   Taché, Yvette ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Gastric motility; Ghrelin; Glucose; Gut brain axis; High fat diet

Indexed keywords

GHRELIN; SOMATOSTATIN; UROCORTIN;

ANIMAL; ARTICLE; BODY WEIGHT; C57BL MOUSE; COMPARATIVE STUDY; DISEASE MODEL; EATING; GLUCOSE BLOOD LEVEL; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LONG EVANS RAT; MALE; METABOLISM; MOUSE; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; STOMACH EMPTYING;

ANIMALS; BLOOD GLUCOSE; DISEASE MODELS, ANIMAL; EATING; GASTRIC EMPTYING; GHRELIN; HUMANS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; MALE; MICE; MICE, INBRED C57BL; OBESITY; RATS; RATS, LONG-EVANS; RATS, SPRAGUE-DAWLEY; SOMATOSTATIN; THINNESS; UROCORTINS;

ANIMALIA; MUS; RATTUS; RODENTIA;

EID: 38049035630     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2007.316     Document Type: Article

References (42)

1. Yach D, Stuckler D, Brownell KD. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med. 2006;12:62-6.
2. Baynes KC, Dhillo WS, Bloom SR. Regulation of food intake by gastrointestinal hormones. Curr Opin Gastroenterol. 2006;22:626-31.
3. Hill JO. Understanding and addressing the epidemic of obesity: an energy balance perspective. Endocr Rev. 2006;27: 750-61.
4. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth- hormone-releasing acylated peptide from stomach. Nature. 1999;402:656-60.
5. van der Lely AJ, Tschop M, Heiman ML, Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev. 2004;25:426-57.
6. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev. 2005;85:495-522.
7. Zorrilla EP, Iwasaki S, Moss JA, et al. Vaccination against weight gain. Proc Natl Acad Sci USA. 2006;103:13226-31.
8. Zhang JV, Ren PG, Avsian-Kretchmer O, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science. 2005;310:996-9.
9. Gourcerol G, Million M, Adelson DW, et al. Lack of interaction between peripheral injection of CCK and obestatin in the regulation of gastric satiety signaling in rodents. Peptides. 2006;27:2811-9.
10. Holst B, Egerod KL, Schild E, et al. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology. 2007;148:13-20.
11. Nogueiras R, Pfluger P, Tovar S, et al. Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology. 2007;148:21-6.
12. Samson WK, White MM, Price C, Ferguson AV. Obestatin acts in brain to inhibit thirst. Am J Physiol Regul Integr Comp Physiol. 2007;292:R637-43.
13. Yamamoto D, Ikeshita N, Daito R, et al. Neither intravenous nor intracerebroventricular administration of obestatin affects the secretion of GH, PRL, TSH and ACTH in rats. Regul Pept. 2007;138:141-4.
14. Bassil AK, Haglund Y, Brown J, et al. Little or no ability of obestatin to interact with ghrelin or modify motility in the rat gastrointestinal tract. Br J Pharmacol. 2007;150:58-64.
15. Gourcerol G, Taché Y. Obestatin: a ghrelin-associated peptide that does not hold its promise to suppress food intake and motility. Neurogastroenterol Motil. 2007;19:161-5.
16. Pan W, Tu H, Kastin AJ. Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin. Peptides. 2006;27:911-6.
17. Wang L, Martinez V, Rivier JE, Taché Y. Peripheral urocortin inhibits gastric emptying and food intake in mice: differential role of CRF receptor 2. Am J Physiol Regul Integr Comp Physiol. 2001;281:R1401-10.
18. Bojo L, Cassuto J, Nellgard P, Jonsson A. Adrenergic, cholinergic and VIP-ergic influence on gastric phasic motility in the rat. Acta Physiol Scand. 1994;150:67-73.
19. Masuda Y, Tanaka T, Inomata N, et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun. 2000;276:905-8.
20. Brown MR, Fisher LA, Spiess J, Rivier C, Rivier J, Vale W. Corticotropin-releasing factor: action on the sympathetic nervous system and metabolism. Endocrinology. 1982;111: 928-31.
21. Taché Y, Rivier J, Vale W, Brown M. Is somatostatin or a somatostatin-like peptide involved in central nervous system control of gastric secretion? Regul Pept. 1981;1:307-15.
22. Yoshida-Yoneda E, Wei JY, Taché Y. Bombesin acts in the brain to decrease gastric vagal efferent discharge in rats. Peptides. 1993;14:339-43.
23. Francis J, Dourish CT, Cooper SJ. Devazepide attenuates dl-fenfluramine-induced suppression of gastric emptying but not food intake in the 17 h food-deprived rat. Physiol Behav. 1997;62:545-50.
24. Adelson DW, Million M, Kanamoto K, Palanca T, Taché Y. Coordinated gastric and sphincter motility evoked by intravenous CCK-8 as monitored by ultrasononomicrometry in rats. Am J Physiol Gastrointest Liver Physiol. 2004;283: G321-32.
25. Seoane LM, Al Massadi O, Pazos Y, Pagotto U, Casanueva FF. Central obestatin administration does not modify either spontaneous or ghrelin-induced food intake in rats. J Endocrinol Invest 2006;29:RC13-5.
26. Tremblay F, Perreault M, Klaman LD, Tobin JF, Smith E, Gimeno RE. Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39. Endocrinology. 2007;148:501-6.
27. Zizzari P, Longchamps R, Epelbaum J, Bluet-Pajot MT. Obestatin partially affects ghrelin stimulation of food intake and GH secretion in rodents. Endocrinology 2007;148:1648-53.
28. De Smet B, Thijs T, Peeters PJ, Depoortere I. Effect of peripheral obestatin on gastric emptying and intestinal contractility in rodents. Neurogastroenterol Motil. 2007;19: 211-7.
29. Niederau C, Meereis-Schwanke K, Klonowski-Stumpe H, Herberg L. CCK-resistance in Zucker obese versus lean rats. Regul Pept. 1997;70:97-104.
30. Asakawa A, Inui A, Ueno N, Makino S, Fujino MA, Kasuga M. Urocortin reduces food intake and gastric emptying in lean and ob/ob obese mice. Gastroenterology. 1999;116: 1287-92.
31. Bang AS, Soule SG, Yandle TG, Richards AM, Pemberton CJ. Characterisation of proghrelin peptides in mammalian tissue and plasma. J Endocrinol. 2007;192:313-23.
32. Sibilia V, Bresciani E, Lattuada N, et al. Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat. J Endocrinol Invest. 2006;29:RC31-4.
33. Carlini VP, Schioth HB, Debarioglio SR. Obestatin improves memory performance and causes anxiolytic effects in rats. Biochem Biophys Res Commun. 2007;352:907-12.
34. Szentirmai E, Krueger JM. Obestatin alters sleep in rats. Neurosci Lett. 2006;404:222-6.
35. Taché Y, Yang H, Miampamba M, Martinez V, Yuan PQ. Role of brainstem TRH/TRH-R1 receptors in the vagal gastric cholinergic response to various stimuli including sham-feeding. Auton Neurosci. 2006;125:42-52.
36. Czimmer J, Million M, Taché Y. Urocortin 2 acts centrally to delay gastric emptying through sympathetic pathways while CRF and urocortin 1 inhibitory actions are vagal dependent in rats. Am J Physiol Gastrointest Liver Physiol. 2006;290:G511-8.
37. Martinez V, Rivier J, Coy D, Taché Y. Intracisternal injection of somatostatin receptor 5- preferring agonists induces a vagal cholinergic stimulation of gastric emptying in rats. J Pharmacol Exp Ther. 2000;293:1099-105.
38. Dezaki K, Hosoda H, Kakei M, et al. Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in beta-cells: implication in the glycemic control in rodents. Diabetes. 2004;53:3142-51.
39. Chanoine JP, Wong AC, Barrios V. Obestatin, acylated and total ghrelin concentrations in the perinatal rat pancreas. Horm Res. 2006;66:81-8.
40. Brown M, Rivier J, Vale W. Somatostatin: central nervous system (CNS) action on glucoregulation. Metabolism. 1977; 27(Suppl 1):1253-6.
41. Luckey A, Wang L, Jamieson PM, et al. Corticotropin-releasing factor receptor 1-deficient mice do not develop postoperative gastric ileus. Gastroenterology. 2003;125: 654-9.
42. Park WH, Oh YJ, Kim GY, et al. Obestatin is not elevated or correlated with insulin in children with Prader-Willi syndrome. J Clin Endocrinol Metab. 2006;92:229-34.